Key facts
- Alyeska Investment Group, L.P. filed SCHEDULE 13G/A for IN8BIO, INC. Common Stock, $0.0001 par value per share (INAB).
- Disclosed ownership: 2.6%.
- Date of event: 30 Jun 2025.
Alyeska Investment Group, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for IN8BIO, INC. Common Stock, $0.0001 par value per share (INAB)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- INAB
- Shares outstanding
- 3,450,426 shares
- Disclosed Ownership
- 89,021 shares
- Ownership
- 2.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 17:50:21 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Key filing fact
Alyeska Investment Group, L.P. disclosed 2.6% ownership in IN8BIO, INC. Common Stock, $0.0001 par value per share (INAB) on 30 Jun 2025.
Change
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 14 Aug 2025, 17:50.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 2.6% | 89,021 | 0 | 89,021 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 2.6% | 89,021 | 0 | 89,021 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 2.6% | 89,021 | 0 | 89,021 | Anand Parekh | Anand Parekh | Self |
CIK / CUSIP context first